National Healthcare Corp NHC
We take great care to ensure that the data presented and summarized in this overview for NATIONAL HEALTHCARE CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NHC
View all- 
    
      Black Rock Inc. New York, NY2.09MShares$254 Million0.01% of portfolio
 - 
    
      Vanguard Group Inc Valley Forge, PA1.44MShares$176 Million0.0% of portfolio
 - 
    
      Dimensional Fund Advisors LP Austin, TX970KShares$118 Million0.02% of portfolio
 - 
    
      Morgan Stanley Institutional Investment Advisors LLC Greenwood Village, CO752KShares$91.6 Million9.96% of portfolio
 - 
    
      State Street Corp Boston, MA493KShares$60 Million0.0% of portfolio
 - 
    
      Jim Simons Renaissance Technologies LLC | New York, Ny387KShares$47.2 Million0.06% of portfolio
 - 
    
      Geode Capital Management, LLC Boston, MA311KShares$37.8 Million0.0% of portfolio
 - 
    
      Charles Schwab Investment Management Inc San Francisco, CA183KShares$22.2 Million0.0% of portfolio
 - 
    
      Alps Advisors Inc Denver, CO147KShares$17.9 Million0.09% of portfolio
 - 
    
      Northern Trust Corp Chicago, IL139KShares$16.9 Million0.0% of portfolio
 
Latest Institutional Activity in NHC
Top Purchases
Top Sells
About NHC
National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living centers offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. It also offers behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, it provides health care programs that offer skilled services, such as infusion, wound care and physical, occupational, and speech therapies; hospice care services; operates pharmacies; offers management, accounting, financial, and insurance services; and leases its properties to third party operators. As of February 18, 2022, the company operated 75 skilled nursing facilities with 9,473 beds, 24 assisted living facilities, five independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. National HealthCare Corporation was founded in 1971 and is based in Murfreesboro, Tennessee.
Insider Transactions at NHC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
           
            Sep 19                          
            2025                          
           
         |           
        Robert G Adams Director | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Indirect | 
           
              4,500
              +24.89%
              
         |   
        
           
              $319,500              
              $71.64 P/Share              
                     
         | 
      
| 
           
            Aug 22                          
            2025                          
           
         |           
        Stephen Fowler Flatt CEO | 
           
              SELL
             
            
                Payment of exercise price or tax liability
             
           | 
        Direct | 
           
              3,146
              -2.57%
              
         |   
        
           
              $358,644              
              $114.82 P/Share              
                     
         | 
      
| 
           
            Aug 22                          
            2025                          
           
         |           
        Stephen Fowler Flatt CEO | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Direct | 
           
              4,000
              +3.17%
              
         |   
        
           
              $296,000              
              $74.02 P/Share              
                     
         | 
      
| 
           
            Aug 13                          
            2025                          
           
         |           
        Josh A Mc Creary Senior VP & General Counsel | 
           
              SELL
             
            
                Payment of exercise price or tax liability
             
           | 
        Direct | 
           
              2,737
              -21.98%
              
         |   
        
           
              $295,596              
              $108.82 P/Share              
                     
         | 
      
| 
           
            Aug 13                          
            2025                          
           
         |           
        Josh A Mc Creary Senior VP & General Counsel | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Direct | 
           
              4,000
              +24.31%
              
         |   
        
           
              $212,000              
              $53.94 P/Share              
                     
         | 
      
| 
           
            Aug 13                          
            2025                          
           
         |           
        James Paul Abernathy Director | 
           
              SELL
             
            
                Payment of exercise price or tax liability
             
           | 
        Direct | 
           
              2,639
              -6.76%
              
         |   
        
           
              $285,012              
              $108.82 P/Share              
                     
         | 
      
| 
           
            Aug 13                          
            2025                          
           
         |           
        James Paul Abernathy Director | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Direct | 
           
              4,010
              +9.32%
              
         |   
        
           
              $284,710              
              $71.64 P/Share              
                     
         | 
      
| 
           
            Jun 26                          
            2025                          
           
         |           
        Robert Michael Ussery President & COO | 
           
              SELL
             
            
                Payment of exercise price or tax liability
             
           | 
        Direct | 
           
              2,007
              -1.25%
              
         |   
        
           
              $218,763              
              $109.05 P/Share              
                     
         | 
      
| 
           
            Jun 26                          
            2025                          
           
         |           
        Robert Michael Ussery President & COO | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Direct | 
           
              4,234
              +2.58%
              
         |   
        
           
              $266,742              
              $63.96 P/Share              
                     
         | 
      
| 
           
            Jun 26                          
            2025                          
           
         |           
        Stephen Fowler Flatt CEO | 
           
              SELL
             
            
                Payment of exercise price or tax liability
             
           | 
        Direct | 
           
              3,557
              -5.71%
              
         |   
        
           
              $387,713              
              $109.05 P/Share              
                     
         | 
      
| 
           
            Jun 26                          
            2025                          
           
         |           
        Stephen Fowler Flatt CEO | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Direct | 
           
              4,734
              +7.06%
              
         |   
        
           
              $298,242              
              $63.96 P/Share              
                     
         | 
      
| 
           
            Jun 26                          
            2025                          
           
         |           
        Vicki L Dodson Sr.VP Patient Srvcs | 
           
              SELL
             
            
                Bona fide gift
             
           | 
        Direct | 
           
              788
              -8.08%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Jun 12                          
            2025                          
           
         |           
        Vicki L Dodson Sr.VP Patient Srvcs | 
           
              SELL
             
            
                Payment of exercise price or tax liability
             
           | 
        Direct | 
           
              5,265
              -22.15%
              
         |   
        
           
              $547,560              
              $104.56 P/Share              
                     
         | 
      
| 
           
            Jun 12                          
            2025                          
           
         |           
        Vicki L Dodson Sr.VP Patient Srvcs | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Direct | 
           
              7,467
              +23.93%
              
         |   
        
           
              $433,086              
              $58.95 P/Share              
                     
         | 
      
| 
           
            Jun 06                          
            2025                          
           
         |           
        Josh A Mc Creary Senior VP & General Counsel | 
           
              SELL
             
            
                Payment of exercise price or tax liability
             
           | 
        Direct | 
           
              2,805
              -24.92%
              
         |   
        
           
              $297,330              
              $106.1 P/Share              
                     
         | 
      
| 
           
            Jun 06                          
            2025                          
           
         |           
        Josh A Mc Creary Senior VP & General Counsel | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Direct | 
           
              3,734
              +24.91%
              
         |   
        
           
              $235,242              
              $63.96 P/Share              
                     
         | 
      
| 
           
            Jun 03                          
            2025                          
           
         |           
        Richard F Laroche Jr Director | 
           
              SELL
             
            
                Bona fide gift
             
           | 
        Direct | 
           
              152
              -0.07%
              
         |   
        
           
              $15,808              
              $104.69 P/Share              
                     
         | 
      
| 
           
            May 16                          
            2025                          
           
         |           
        Brian F Kidd SVP, CFO | 
           
              SELL
             
            
                Payment of exercise price or tax liability
             
           | 
        Direct | 
           
              2,701
              -10.23%
              
         |   
        
           
              $291,708              
              $108.61 P/Share              
                     
         | 
      
| 
           
            May 16                          
            2025                          
           
         |           
        Brian F Kidd SVP, CFO | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Direct | 
           
              3,734
              +12.39%
              
         |   
        
           
              $235,242              
              $63.96 P/Share              
                     
         | 
      
| 
           
            May 05                          
            2025                          
           
         |           
        Richard F Laroche Jr Director | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Direct | 
           
              5,000
              +2.37%
              
         |   
        
           
              $320,000              
              $64.64 P/Share              
                     
         | 
      
Last 12 Months Summary
| Exercise of conversion of derivative security | 64K shares | 
|---|---|
| Grant, award, or other acquisition | 10.6K shares | 
| Payment of exercise price or tax liability | 29.3K shares | 
|---|---|
| Bona fide gift | 2.07K shares | 
| Open market or private sale | 54.5K shares |